Volatile Biomarkers for Health Monitoring

Parkinson’s disease (PD), the second most common progressive neurodegenerative disease, develops and progresses for 10-15 years or more before the clinical diagnostic symptoms of the disease occur.  Finding reliable, specific, and highly predictive biomarkers during the latent period of the disease is a substantial challenge for the success of PD curative or preventive strategies and…

More